Webinar Collections

A comprehensive list of all the different Consult Dr. A Webinar Collections

PHARM Part 1-23

#3 PHARM Part 1 – Cortisol and Adrenal Therapies

#4 PHARM Part 2 – T3 and Iodine Rx & Safe Dosing

#5 PHARM Part 3 – Desiccated Thyroid Rx Management

#12 PHARM Part 4- Antidepressant Pharmacology and Tapering

#13 PHARM Part 5 – Pediatric Posing Strategies

#15 PHARM Part 6 – Kidney Disease Management & Pharmacology

#16 PHARM Part 7 – Blood Pressure and Cardiac Pharmacology & Management

#17 PHARM Part 8 – Respiratory Pharmacology Part 1: Prescription Management

#22 PHARM Part 9 – Chronic Pain Medication Weaning

#26 PHARM Part 10 – ADHD Medication Pharmacology and Weaning

#27 PHARM Part 11 – Seizure (Epilepsy) Medication Pharmacology and Weaning

#29 PHARM Part 12 – Medical Cannabinoids Pharmacology and Clinical Use

#35 PHARM Part 13 – Migraine Assessment & Treatment

#42 PHARM Part 14 – NAD Therapies

#44 PHARM Part 15 – Acute Use of Thyroid & Adrenal Rx

#46 Respiratory Pharmacology Part 2 – Natural Therapies Nebulizer & Others

#49 PHARM Part 16 – Bipolar Spectrum and Seizure Pharmacological & Natural Therapies

#55 PHARM Part 17 – Benzodiazepines Pharmacology Prescribing Tapering & Management

#57 PHARM Part 18 – Strong Botanicals (“Low Dose”, “Toxic”, “Eclectic”, etc) Pharmacology Dosing Clinical Use Safety

#60 PHARM Part 19 – Advanced Adrenal Assessment & Therapies

#64 PHARM Part 20 – Repurposed Drugs in Oncology

#73 PHARM Part 22 – Vitamin C Uses: Clinical Q & A Part 1

#74 PHARM Part 23 – Vitamin C Uses: Pharmacology, Safety, & Clinical Tips Q & A Part

NEURO Part 1-7

#30 NEURO Part 1 – Neurological Therapies

#39 NEURO Part 2 – Dysautonmia and EDS

#51 NEURO Part 3 – Neurological Autoimmunity Part 1 of 2

#52 NEURO Part 4 – Neurological Autoimmunity Part 2 of 2

#54 NEURO Part 5 – Neurological Manifestations in Chronic Patients: Assessment & Management

AUTOIMMUNITY Part 1 & 2

#6 Autoimmunity Part 1 – Overview and Case Management

#18 Autoimmunity Part 2 – Case Management

HBOT Part 1 & 2

#32 HBOT Part 1 – Hyperbaric Oxygen Therapies General

#50 HBOT Part 2 – Neurological and Cancer Primary Considerations

IV INJECTION Part 1-3

#10 IV INJECTION Q & A Part 1

#25 IV INJECTION Q & A Part 2

#69 Injection Updates IM & SQ

GI Part 1-7

#38 GI Part 1 – Nutrient Absorption & GI Health

#68 GI Part 2 – GI Function & Therapeutics

#76 Blood-Brain & GI Barrier Connection: Implications, Identification, and Treatment Strategies

#86 GI Cancer & Microbiome Considerations

#91 GI Pharmacology: Infectious Diseases

#94 The Microbiome and Cancer – With a GI Cancer Updates

#98 Toxicity & the GI Tract: Assessment & Therapies

DETOXIFICATION Part 1-6

#11 Detoxification – Sulfite Toxicity & Sulfation Pathways

#21 DETOXIFICATION Part 1 – Oral Chelation

#37 DETOXIFICATION Part 2 – Fluoroquinolone Toxicity

#41 DETOXIFICATION Part 3 – Detox of Unusual Metals

#59 DETOXIFICATION Part 4 – Metabolic Toxins

#92 DETOXIFICATION Part 5 – Detoxification & Depuration of Toxicants: Integrated Strategies

COVID-19 Part 1-3

#62 COVID-19 Part 1 – Clinician Updates

#71 Post-COVID Syndrome

#87 COVID & The Nervous System

CHRONIC INFECTIONS Part 1-4

#19 CHRONIC INFECTIONS Part 1 – Assessment & Reassessment

#20 CHRONIC INFECTIONS Part 2 – Infectious Agents Lyme & Others

#56 CHRONIC INFECTIONS Part 3 – Pharmaceutical Agent Management

#58 CHRONIC INFECTIONS Part 4 – Natural Agent Management

ASSESSMENTS Part 1-12

#23 ASSESSMENT Part 1 – Chronic Cases Review & Clinical Thinking

#45 ASSESSMENT Part 2 – Naturopathic & Integrative Thought for the 21st Century

#48 ASSESSMENT Part 3 – Assessing the Complex Patient

#53 ASSESSMENT Part 4 – Interrelationships in Chronic Disease

#61 ASSESSMENT Part 5 – Red Flags & Critical Management

#63 ASSESSMENT Part 6 – Managing Comorbidity in Chronic Cases

#79 ASSESSMENT Part 7 – Laboratory Medicine Series Part 1

#80 ASSESSMENT Part 8 – Laboratory Medicine Series Part 2

#81 ASSESSMENT Part 9 – Laboratory Medicine Series Part 3: GI Lab Considerations

#82 ASSESSMENT Part 10 – Laboratory Medicine Series Part 4

#83 ASSESSMENT Part 11 – Chronic Viral Case Assessment

#84 ASSESSMENT Part 12 – Laboratory Medicine Series Part 5: Hematology

LABORATORY MEDICINE Part 1-7

#34 Organic Acid Testing (OAT) & Interpretation

#79 Laboratory Medicine Series Part 1

#80 Laboratory Medicine Series Part 2

#81 Laboratory Medicine Series Part 3 – GI Lab Considerations

#82 ASSESSMENT Part 10 – Laboratory Medicine Series Part 4

#84 ASSESSMENT Part 12 – Laboratory Medicine Series Part 5: Hematology

#85 Laboratory Medicine Series Part 6

#99 Advanced Lipid Assessment – Laboratory

IMMUNOLOGY Part 1-5

#28 IMMUNOLOGY Part 1 – Low Dose Naltrexone

#40 IMMUNOLOGY Part 2 – Low Dose Immunotherapy (LDI)

#65 IMMUNOLOGY Part 3 – Immunology Clinician Update

#67 IMMUNOLOGY Part 4 – Natural Immunologic Agents

#75 IMMUNOLOGY Part 5 – Functional Immunology & Updates on TH1/2/17 Balance

RESPIRATORY PHARMACOLOGY Part 1 & 2

#17 PHARM Part 8 – Respiratory Pharmacology Part 1: Prescription Management

#46 Respiratory Pharmacology Part 2 – Natural Therapies Nebulizer & Others

#64 PHARM Part 20 – Repurposed Drugs in Oncology

#66 Controversies in Oncology – Keeping the Patient Safe

#70 Toxins, Immune Function, and Cancer

#86 GI Cancer & Microbiome Considerations

#88 Advanced Prostate Cancer

#90 Oncology: Caring for People With Cancer Through the 4 Phases of Cancer

#94 The Microbiome and Cancer – With a GI Cancer Update

LOW DOSE NALTREXONE Part 1 & 2

#51 NEURO Part 3 – Neurological Autoimmunity

#78 LDN Updates & Dosing Information

#16 PHARM Part 7 – Blood Pressure and Cardiac Pharmacology and Management

#93 Cardiology Updates: Pathophysiology & Pharmacology

#95 Cardiac Dysrhythmia: Pharmacology & Integrative Care Management

#99 Advanced Lipid Assessment: Laboratory Evaluation & Management

#7 Histamine Triggers MCAS and Therapies

#100 MCAS Part 2

#109 MCAS Part 3

#111 Glutathione and Redox: A-Z Part 1

#113 Glutathione and Redox: A-Z Part 2

Scroll to Top